The Carnitine System
New Therapeutical Approach to Cardiovascular Diseases
1st Edition
Published on 30. June 1995
Book
Hardback
400 pages
978-0-7923-3318-0 (ISBN)
Description
In the last few years, derivatives of L-carnitine, such as acetyl-L-carnitine and propionyl-L-carnitine, have been made available to doctors for treatment of specific pathologies. The effects of this family of related carnitine compounds on cardiovascular systems and diseases constitute the major issue addressed in this book. This text provides the reader with a concise update in this field. The information collected from experts on various aspects of carnitine should be useful for both clinicians and basic scientists.
More details
Series
Language
English
Place of publication
United States
Target group
Professional and scholarly
Research
Illustrations
32 s/w Tabellen
Illustrations
Dimensions
Height: 240 mm
Width: 160 mm
Weight
882 gr
ISBN-13
978-0-7923-3318-0 (9780792333180)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions
J.W. de Jong | R. Ferrari
The Carnitine System
A New Therapeutical Approach to Cardiovascular Diseases
Book
01/2012
Springer
€53.49
Shipment within 15-20 days
Content
Part I: The Carnitine System in the Heart: Molecular Aspects. Carnitine-dependent pathways in heart muscle; J. Bremer. Carnitine and carnitine esters in mitochondrial metabolism and function; F. di Lisa, R. Barbato, R. Menabo, N. Siliprandi. The effects of carnitine on myocardial carbohydrate metabolism; B.R. Schonekess, G.D. Lopaschuk. Accumulation of fatty acids and their carnitine derivatives during myocardial ischemia; G.J. van der Vusse. Carnitine acylcarnitine translocase in ischemia; J.B. McMillin. Amphiphilic interaction of long-chain fatty acylcarnitines with membranes: potential involvement in ischemic injury; J.M.J. Lamers. Mitochondrial injury in the ischemic-reoxygenated cardiomyocyte - The role of lipids and other pathogenic facts; H.M. Piper, T. Noll, B. Siegmund. Free radical-mediated damage and carnitine esters; J.F. Koster. Carnitine transport in volume-overloaded rat hearts; J. Moravec, Z. El Alaoui-Tablibi, C. Brunold. Myocardial carnitine deficiency in human cardiomyopathy; V. Regitz-Zagrosek, E. Fleck. Part II: Therapeutic Efficacy of L-Carnitine at the Myocardial Level. Is the carnitine system part of the heart antioxidant network? A. Arduini, F. Molajoni, R. Kirk, E. Arrigoni Martelli. Experimental evidence of the anti-ischemic effect of L-carnitine; D.J. Paulson, A.L. Shug. Carnitine metabolism during diabetes and hyperthyroidy; D. Feuvray. Carnitine and lactate metabolism; R. Ferrari, O. Visioli. Therapeutic potential of L-carnitine in patients with angina pectoris; C.J. Pepine, M.A. Welsch. Carnitine and myocardial infarction; P. Mizzon, M. di Viase, G. Biasco, M.V. Pitzalis. Part III: Therapeutic Efficacy of Propionyl-L-Carnitine. Cardiac electrophysiology of propionyl-L-carnitine; A. Mugelli, E. Carbai, M. Barbieri. Acute vs. chronic treatment with propionyl-L-carnitine: biochemical, hemodynamic and electrophysiological effects on rabbit heart; J.W. de Jong, A. Mugelli, F. di Lisa, R. Ferrari. Mechanical recovery with propionyl-L-carnitine; A.J. Liedtke. Dissociation of hemodynamic and metabolic effects of propionyl-L-carnitine in ischemic pig heart; P.D. Verdouw, L.M.A. Sassen, D.J. Duncker, J.M.J. Lamers. Effect of propionyl-L-carnitine on rats with experimentally induced cardiomyopathies; R. Micheletti, A. Schiavone, G. Bianchi. Utilization of propionyl-L-carnitine for the treatment of heart failure; R. Ferrari, I. Anand. Hemodynamic and metabolic effect of propionyl-L-carnitine in patients with heart failure; S. Caponnetto, C. Brunelli. Carnitine metabolism in peripheral arterial disease; W.R. Hiatt, E.P. Brass. Effect of propionyl-L-carnitine on experimental models of peripheral arteriopathy in the rat; N. Corsico, E. Arrigoni-Martelli. (Part contents).